BQ‐788, A Selective Endothelin ETBReceptor Antagonist
Authors:
Open Access
- 1 March 2002
- journal article
- Published by Wiley in Cardiovascular Drug Reviews
- Vol. 20 (1) , 53-66
Abstract
We describe characteristics of a selective endothelin (ET) ETBreceptor antagonist, BQ‐788 [N‐cis‐2,6‐dimethylpiperidinocarbonyl‐L‐γ‐methylleucyl‐D‐1‐methoxycarbonyltryptophanyl‐D‐norleucine], which is widely used to demonstrate the role of endogenous or exogenous ETsin vitroandin vivo. In vitro, BQ‐788 potently and competitively inhibited125I‐labeled ET‐1 binding to ETBreceptors in human Girrardi heart cells (hGH) with an IC50of 1.2 nM, but only poorly inhibited the binding to ETAreceptors in human neuroblastoma cell line SK‐N‐MC cells (IC50, 1300 nM). In isolated rabbit pulmonary arteries, BQ‐788 showed no agonistic activity up to 10 μ and competitively inhibited the vasoconstriction induced by an ETB‐selective agonist (pA2, 8.4). BQ‐788 also inhibited several bioactivities of ET‐1, such as bronchoconstriction, cell proliferation, and clearance of perfused ET‐1. Thus, it is confirmed that BQ‐788 is a potent, selective ETBreceptor antagonist.In vivo, in conscious rats, BQ‐788, 3 mg/kg/h, i.v., completely inhibited a pharmacological dose of ET‐1‐ or sarafotoxin6c (S6c) (0.5 nmol/kg, i.v.)‐induced ETBreceptor‐mediated depressor, but not pressor responses. Furthermore, BQ‐788 markedly increased the plasma concentration of ET‐1, which is considered an index of potential ETBreceptor blockadein vivo.In Dahl salt‐sensitive hypertensive (DS) rats, BQ‐788, 3 mg/kg/h, i.v., increased blood pressure by about 20 mm Hg. It is reported that BQ‐788 also inhibited ET‐1‐induced bronchoconstriction, tumor growth and lipopolysaccharide‐induced organ failure. These data suggest that BQ‐788 is a good tool for demonstrating the role of ET‐1 and ETBreceptor subtypes in physiological and/or pathophysiological conditions.Keywords
This publication has 54 references indexed in Scilit:
- Selective and non-selective et antagonists reveal an ETA/ETB receptor mediated ET-1-induced antinociceptive effect in PAG area of miceLife Sciences, 1997
- ETA and ETB Receptors Coexist on Rabbit Pulmonary Artery Vascular Smooth Muscle Mediating ContractionBiochemical and Biophysical Research Communications, 1993
- Antihypertensive effect of a newly synthesized endothelin antagonist, BQ-123, in a genetic hypertensive modelLife Sciences, 1993
- Analysis of responses to endothelins in isolated porcine blood vessels by using a novel endothelin antagonist, BQ-153Life Sciences, 1992
- Endothelin and structurally related analogs distinguish between endothelin receptor subtypesBiochemical and Biophysical Research Communications, 1992
- A novel radioligand [125I]BQ-3020 selective for endothelin (ETB) receptorsLife Sciences, 1992
- Biological profiles of highly potent novel endothelin antagonists selective for the ETA receptorLife Sciences, 1992
- Molecular cloning of a non-isopeptide-selective human endothelin receptorBiochemical and Biophysical Research Communications, 1991
- Cloning and sequence analysis of a cDNA encoding human non-selective type of endothelin receptorBiochemical and Biophysical Research Communications, 1991
- Autoradiographic visualization of the binding sites for [125I]endothelin in rat and human brainNeuroscience Letters, 1989